Rochester, MN, United States of America

Adele Fielding


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Adele Fielding: Innovator in Cancer Treatment

Introduction

Adele Fielding is a prominent inventor based in Rochester, MN (US), known for her groundbreaking work in cancer treatment. With a total of two patents to her name, she has made significant contributions to the medical field, particularly in the use of attenuated viruses for therapeutic purposes.

Latest Patents

Fielding's latest patents focus on a method for limiting the growth of cancer cells using an attenuated measles virus. This innovative approach involves administering a therapeutically effective dose of the virus, either directly or systemically. In one embodiment, the effective dose ranges from about 10 pfu to about 10 pfu, delivered through direct injection into cancer cells or via intravenous injection. This method represents a promising avenue for cancer treatment, showcasing her commitment to advancing medical science.

Career Highlights

Fielding is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to develop her research and innovations. Her work has garnered attention for its potential to change the landscape of cancer therapies, making her a key figure in the field.

Collaborations

Fielding has collaborated with notable colleagues, including Stephen James Russell and Kah-Whye Peng, further enhancing her research and contributions to cancer treatment.

Conclusion

Adele Fielding's innovative work in cancer treatment through the use of attenuated measles virus exemplifies her dedication to improving patient outcomes. Her patents and collaborations highlight her significant role in advancing medical research and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…